A Feasibility Study to Detect Neonatal Hypoglycemia in Infants of Diabetic Mothers Using Real-Time Continuous Glucose Monitoring
العنوان: | A Feasibility Study to Detect Neonatal Hypoglycemia in Infants of Diabetic Mothers Using Real-Time Continuous Glucose Monitoring |
---|---|
المؤلفون: | Bruce A. Buckingham, Laura M. Nally, Nicholas Bondy, Darrell M. Wilson, Jasmine Doiev |
المصدر: | Diabetes Technology & Therapeutics. 21:170-176 |
بيانات النشر: | Mary Ann Liebert Inc, 2019. |
سنة النشر: | 2019 |
مصطلحات موضوعية: | Adult, Blood Glucose, Male, Pediatrics, medicine.medical_specialty, endocrine system diseases, Endocrinology, Diabetes and Metabolism, 030209 endocrinology & metabolism, Hypoglycemia, Asymptomatic, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Child of Impaired Parents, Pregnancy, Diabetes mellitus, medicine, Humans, 030212 general & internal medicine, Monitoring, Physiologic, Continuous glucose monitoring, business.industry, Neonatal hypoglycemia, Infant, Newborn, food and beverages, nutritional and metabolic diseases, medicine.disease, Diabetes, Gestational, Medical Laboratory Technology, Diabetes Mellitus, Type 1, Feasibility Studies, Female, Glucose monitors, medicine.symptom, business |
الوصف: | Infants born to mothers with diabetes commonly experience asymptomatic hypoglycemia after birth. Continuous glucose monitors (CGM) can detect asymptomatic hypoglycemia in this population without the need for painful glucose checks.Infants born after 34 weeks of gestation to mothers with diabetes had a CGM placed after birth. One group of infants was remotely monitored in real-time by research staff during the hospitalization, whereas another group wore a blinded CGM. In both groups, hospital standard-of-care (SOC) glucose checks were performed. Clinical staff and families were blinded to CGM data. For CGM readings45 mg/dL, research staff requested a verification blood glucose (BG) using the point-of-care glucometer.Sixteen infants were studied; 4 with a blinded CGM and 12 with remote monitoring (RM). When there were confirmatory hospital glucometer readings, the sensitivity of the CGM to detect hypoglycemia was 86% and the specificity was 91%. The positive predictive value was 55% and the negative predictive value was 98%. In the full cohort, hypoglycemia (45 mg/dL) was confirmed in 12 of 16 infants with 30 events at12 hours of life (HOL), 3 events between 12 and 24 HOL, and 1 event at48 HOL. In the RM group, CGM detected hypoglycemia five times when the infant was not due for a BG check based on the SOC. Overall, the CGM detected five false-positive alerts and six true-positive alerts for hypoglycemia. Only one hypoglycemic episode was missed by CGM in the RM group. Barriers to recruitment included fear of pain with glucose checks, concerns with CGM use, satisfaction with the hospital SOC, personal reasons independent of the study, and lack of interest in participating in research.Although there were barriers to recruitment and retention in the study, we conclude that CGM can provide added benefit for detecting hypoglycemia when used early after birth. |
تدمد: | 1557-8593 1520-9156 |
الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eddce006f29f22b2ff388fc0c855f8b4Test https://doi.org/10.1089/dia.2018.0337Test |
حقوق: | CLOSED |
رقم الانضمام: | edsair.doi.dedup.....eddce006f29f22b2ff388fc0c855f8b4 |
قاعدة البيانات: | OpenAIRE |
تدمد: | 15578593 15209156 |
---|